Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

June 17th 2020, Crypto Chartbook: Failure equals big money

Failure equals big money If that be the case we’d be all rich trading the markets. No, what we are referring here to is pattern failure. Chart patterns have probabilities of how often they work. Most bet in favor of the favorable outcome of such patterns. ...
Korbinian Koller | June 17, 2020 |

Crude Oil’s Failure Leads to a Profitable Opportunity

Crude oil moved sharply higher yesterday, almost touching the previous August highs, but it didn’t manage to break above them. The resistance that we outlined in the previous Oil Trading Alerts kept the rally in check, and we already see the result. Crude oil s...
Nadia Simmons | August 30, 2019 |

When You Reward Failure, You Encourage Fraud

Bob Moriarty of 321gold expresses his views on the potential bailout of industries. When the banking system was on the verge of complete failure in 2008, during the Great Financial Crisis (GFC), the world had a wonderful opportunity to do a total financial r...
Streetwise Reports | March 20, 2020 |

CytoSorbents Shares Trade 20% Higher as FDA Grants CytoSorb EUA for COVID-19

Shares of CytoSorbents traded higher setting a new 52-week intraday high price after the company reported that the FDA granted emergency use authorization for CytoSorb for use in patients with COVID-19. Critical care immunotherapy company CytoSorbents Corp....
Streetwise Reports | April 14, 2020 |

MATIC, Ripple and Tron – Daily Analysis – 12/12/19

MATIC leads the way down as the majors see red once more. Things could get messy… Bob Mason MATIC Network’s MATIC MATIC rose by 3.52% on Wednesday. Following a 49.52% tumble on...
FX Empire | December 13, 2019 |

'Stay Tuned for Data' from Regenerative Medicine Firm with 'Blockbuster Opportunity'

The compelling aspects of this life sciences story are presented in a Dawson James report. In a Jan. 28 research note, analyst Jason Kolbert reported that Dawson James Securities increased its target price on Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX) to $15 pe...
Streetwise Reports | February 3, 2020 |

Are Metals Beginning Another Rally Attempt?

Recently, the US stock market rallied to new all-time highs which prompted an almost immediate celebration. A day later, the US stock markets reacted by setting up multiple top rotation patterns. The next day, a moderate price rally set up after the US Fed decreased rates by 2...
Chris Vermeulen | November 4, 2019 |

Revolutionizing vascular grafting with a durable solution

Our next guest is a multi-technology biomedical company, focused on the development and commercialization of medical technologies. Marizyme Inc. (OTCQB:MRZM) has had its sights set on development of medical technology and products, one of which is DuraGraft. J...
Brieanna McCutcheon | September 27, 2023 |

IS THIS THE START OF THE NEXT BEAR MARKET?

Over the past few days, we've received hundreds of emails from our followers and members asking if this is the big breakdown that everyone has been expecting in the markets. Yes, we've warned that it will likely happen before the end of 2019, but we've also been very clear t...
Chris Vermeulen | August 7, 2019 |

Chimerix Shares Rise 50% as FDA Gives 'Go Ahead' for Phase 2/3 ALI Study in COVID-19 Patients

Shares of Chimerix Inc. traded higher after the company reported it has received U.S. FDA clearance to initiate a Phase 2/3 Study of dociparstat sodium in acute lung injury for patients afflicted with severe COVID-19. Biopharmaceutical company Chimerix Inc....
Streetwise Reports | April 29, 2020 |
1 2 3 4 5 6 7 8 9 10 ...